Cargando…
Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform
Peptide antigens are combined with an adjuvant in order to increase immunogenicity in vivo. The immunogenicity and safety of a RSV vaccine formulated in a novel oil-based platform, DepoVax™ (DPX), was compared to an alum formulation. A peptide B cell epitope derived from RSV small hydrophobic ectodo...
Autores principales: | MacDonald, Lisa D., MacKay, Alecia, Kaliaperumal, Valarmathy, Weir, Genevieve, Penwell, Andrea, Rajagopalan, Rajkannan, Langley, Joanne M., Halperin, Scott, Mansour, Marc, Stanford, Marianne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791585/ https://www.ncbi.nlm.nih.gov/pubmed/28933663 http://dx.doi.org/10.1080/21645515.2017.1375637 |
Ejemplares similares
-
Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control
por: Brewer, Kimberly D., et al.
Publicado: (2018) -
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillusanthracis spore inhalation challenge
por: Weir, Genevieve M., et al.
Publicado: (2019) -
Generation of highly activated, antigen-specific tumor-infiltrating CD8(+) T cells induced by a novel T cell-targeted immunotherapy
por: Vila-Leahey, Ava, et al.
Publicado: (2020) -
Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics
por: Kotraiah, Vinayaka, et al.
Publicado: (2020) -
Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein
por: Torrey, Heather L., et al.
Publicado: (2020)